Trials / Completed
CompletedNCT01881386
Lactate Imaging as a Tumour Biomarker
Investigation of Lactate Measured Using Magnetic Resonance Spectroscopy as a Biomarker of Tumour Response
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Institute of Cancer Research, United Kingdom · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This project is designed to investigate whether measurements of lactate in tumours, made using a magnetic resonance technique similar to MRI, is an effective non-invasive method to detect whether some new targeted drugs are having their desired effect. The study hypothesis is that by using magnetic resonance spectroscopy techniques, we will be able to observe changes in tumour lactate levels in vivo, in response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic Resonance Imaging (MRI) | Magnetic Resonance Spectroscopy |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2013-06-19
- Last updated
- 2020-01-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01881386. Inclusion in this directory is not an endorsement.